Erik Teugels

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

Jacques De Grève, Erik Teugels, Caroline Geers et al. · Lung Cancer · 2012 · 277 citations · Full text

miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells

Gang Chen, Ijeoma Adaku Umelo, Shasha Lv et al. · PLoS ONE · 2013 · 266 citations · Full text

Immunology, Cell Death, Cancer Biology +20

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

Gang Chen, Peter Kronenberger, Erik Teugels et al. · BMC Medicine · 2012 · 126 citations · Full text

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib

Amir Noeparast, Erik Teugels, Philippe Giron et al. · Oncotarget · 2016 · 100 citations · Full text

Braf Kinase Activity, Impaired Braf Kinases, Pathology +17

De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes

Erik Teugels, Sylvia De Brakeleer, Guido Goelen et al. · Human Mutation · 2005 · 99 citations · Full text